Skip to main content
. 2022 May 25;22:452. doi: 10.1186/s12877-022-03128-x

Table 4.

Summary EQ-5D-5L domain data at baseline and follow-up by treatment arm

Intervention Control
Dimensions Levels Baseline Follow-up Baseline Follow-up
(6 months) (6 months)
N = 34 N = 34 N = 31 N = 26
N (%) N (%) N (%) N (%)
Mobility
None 7(20.59) 4(11.76) 6(19.35) 5(19.23)
Slight 11(32.35) 15(44.12) 10(32.26) 10(38.46)
Moderate 14(41.18) 9(26.47) 9(29.03) 5(19.23)
Severe 2(5.88) 6(17.65) 4(12.90) 6(23.00)
Unable 0.00 0.00 2(6.45) 0.00
Self-care
None 27(79.41) 24(70.59) 22(70.97) 13(50.00)
Slight 2(5.88) 5(14.71) 5(16.13) 4(15.38)
Moderate 5(14.71) 4(11.76) 1(3.23) 4(15.38)
Severe 0.00 1((2.94) 1(3.23) 3(11.54)
Unable 0.00 0.00 2(6.45) 2(7.69)
Usual activities
None 11(32.35) 11(32.35) 14(45.16) 8(30.77)
Slight 14(41.18) 13(38.24) 3(9.68) 6(23.08)
Moderate 5(14.71) 5(14.71) 8(25.81) 5(19.23)
Severe 3(8.82) 5(14.71) 1(3.23) 3(11.54)
Unable 1(2.94) 0.00 5(16.13) 4(15.38)
Pain/Discomfort
None 7(20.59) 5(14.71) 10(32.26) 11(42.31)
Slight 14(41.18) 11(32.35) 8(25.81) 9(34.62)
Moderate 11(32.35) 13(38.24) 12(38.71) 6(23.08)
Severe 2(5.88) 3(8.82) 1(3.23) 0.00
Extreme 0.00 2(5.88) 0.00 0.00
Anxiety/Depression
None 18(52.94) 18(52.94) 12(38.71) 16(61.54)
Slight 12(35.29) 11(32.35) 12(38.71) 5(19.23)
Moderate 3(8.82) 4(11.76) 6(19.35) 5(19.23)
Severe 1(2.94) 1(2.94) 1(3.23) 0.00
Extreme 0.00 0.00 0.00 0.00